cancer
Generon’s Recombinant IL-22 Receives US FDA Clearance For Phase IIa Trials
Following a successful Phase I study, Generon is moving its recombinant antibody F-652 to Phase IIa trials in collaboration with the Memorial Sloan-Kettering Cancer Center.
Prima BioMed Announces Japanese Collaboration
Prima BioMed and Japanese partners NEC and Yamaguchi University are investigating the use of an adjuvant for a potential liver cancer vaccine.
Japan’s NCC & Takeda Enter Research Partnership
The collaboration between the National Cancer Center and Takeda is part of a wider academic-industrial effort to develop new medicines.
How mRNA Splicing Defects Trigger Cancer
Disruption of normal mRNA splicing can lead to DNA damage and the activation of apoptosis, according to a study in flies.
CBMG Expands Beijing GMP Facility
CBMG will open a third GMP facility in Beijing to develop their immunotherapy platform, CAR-T.
Sensing Tension In The Plasma Membrane
The membrane-bending protein FBP17 has been identified as a sensor of cell surface tension that can regulate cell migration through actin polyermization.
Clearbridge & LIDE Launch China’s First CTC Hub
Clearbridge Biomedics has partnered LIDE Biotech to bring circulating tumor cell isolation technology to China.
Treating Colon Cancer With Leukemia Drug
A study in mice suggests that the leukemia drug Imatinib could also be used to treat and prevent colon cancer.
Nanomaterial “Sniper” Targets Cancer Stem Cells
A nanomaterial that effectively targets cancer stem cells without harming non-cancerous cells shows significant therapeutic potential.
